Stocktoria
Astrana Health, Inc. ASTH
Nasdaq · XNAS · stock · Services-Management Consulting Services · website · IPO 1999-04-09
Astrana Health, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 2.5% | 4.4% | 6.1% | 9.1% | 12.7% |
| Net margin | 0.7% | 2.1% | 4.4% | 3.9% | 8.9% |
| FCF margin | 3.3% | 2.2% | 2.9% | 5.2% | 6.6% |
| Return on assets | 1.0% | 3.2% | 6.5% | 4.7% | 8.1% |
| Return on equity | 2.8% | 6.0% | 9.8% | 8.3% | 15.2% |
| Debt / equity | 1.25× | 0.59× | 0.42× | 0.37× | 0.40× |
| Current ratio | 1.40 | 1.75 | 2.11 | 2.88 | 3.46 |
| Revenue growth | 56.4% | 46.7% | 21.2% | 47.8% | 12.6% |
Source: SEC EDGAR filings · CIK 0001083446 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.